HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xavier Canron Selected Research

cyclo-VEGI

8/2005Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.
7/2004Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
9/2003Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xavier Canron Research Topics

Disease

5Neoplasms (Cancer)
10/2007 - 09/2003
2Glioma (Gliomas)
09/2003 - 12/2002
1Hepatocellular Carcinoma (Hepatoma)
10/2007
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2004

Drug/Important Bio-Agent (IBA)

3cyclo-VEGIIBA
08/2005 - 09/2003
1CeramidesIBA
10/2007
1DNA HelicasesIBA
10/2007
1beta CateninIBA
10/2007
1Adenosine Triphosphatases (ATPase)IBA
10/2007
1AgarIBA
10/2007
1Messenger RNA (mRNA)IBA
10/2007
1Small Interfering RNA (siRNA)IBA
10/2007
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2006
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
11/2006
1matrigelIBA
04/2004
1Growth InhibitorsIBA
09/2003
1Angiogenesis InhibitorsIBA
09/2003
1N 30IBA
12/2002
1Peptides (Polypeptides)IBA
12/2002

Therapy/Procedure

1Therapeutics
11/2006